
Computation-Driven Innovative Drug R&D Provider
According to the Zhitong Finance APP, a report from the "Goldport Capital" WeChat Official Account stated that recently, Shenzhen Laihaoshi Technology Co., Ltd. (hereinafter referred to as "Laihaoshi") completed an angel round of financing worth tens of millions of yuan. The round was led by Goldport Capital, with XtalPi participating as a follow-up investor. The funds will be used for enterprise product research and development, production, and market expansion.
According to publicly available information, Shenzhen Laihaoshi Technology Co., Ltd. was established in December 2022. It is dedicated to providing intelligent and automated tools for laboratories in the life sciences field, such as drug research and development, in vitro diagnostics, and synthetic biology, and offers highly efficient smart products tailored to life science application scenarios.